市場調査レポート

商品コード

1098609

低分子注射剤の市場規模・シェア・展望・機会 (2022年～2030年)：薬剤クラス・適応症・投薬モード・エンドユーザー・地域別

Small Molecule Injectable Drugs Market, by Drug Class, by Indication, by Mode of Delivery, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: 2022年06月06日 | 発行: Coherent Market Insights

| ページ情報: 英文 408 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 705,420円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,097,320円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,567,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

参入事業者による新しい製造施設での注射薬の生産開始や、新しい低分子注射剤の規制当局からの承認取得などの要因が予測期間中の世界の低分子注射剤市場の成長を促進すると予測されています。

当レポートでは、世界の低分子注射剤の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

企業プロファイル
- Novartis AG
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Merck &Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma Ltd.
- AstraZeneca Plc
- Baxter International Inc.
- Fresenius Kabi AG
- Cipla Limited.
- Mylan NV
- GlaxoSmithKline Plc.
- Johnson &Johnson
- Sanofi SA
- Reddy's Laboratories Ltd.
- Hoffmann-La Roche AG(Genentech, Inc.)
- Amgen, Inc.
- Gilead Sciences, Inc.
- Hikma Pharmaceuticals plc
アナリストの見解

第11章セクション

Product Code: CMI5033

The term 'small molecule' or low-molecular-weight organic compound means that the drug can be administered orally or that it can be injected through parenteral routes. Small-molecule injectable drugs are used in the treatment of oncology disorders, infectious diseases, blood diseases, and cardiovascular diseases.

Moreover, the small-molecule drugs are very easy to synthesize and can be produced in large quantities and also these drugs are very simple to manufacture, which leads to strong generic competition among market players. As small molecules typically work by mimicking biological substrates or allosterically targeting hydrophobic pockets of proteins, certain biological targets may not be druggable. Many bacterial and cancer cells have developed resistance to small-molecule drugs through mechanisms such as chemoenzymatic modifications, efflux pumps, drug target mutations, etc.

Market Dynamics

Market players are initiating production of injectable drugs in the new manufacturing facility, which is expected to drive growth of the global small molecule injectable drugs, over the forecast period. For instance, in August 2018, Pfizer Inc., a pharmaceutical and Biotechnology Corporation, announced injectable production at Portage in Kalamazoo, Michigan. The plant will enable Pfizer to produce injectable medicines for patients suffering from chronic diseases such as oncology, across the globe, as well as supporting the company's supply capacity and production.

Key players are involved in receiving approvals from regulatory authorities for new small molecule injectable drugs. This is expected to drive growth of the global small molecule injectable drugs market, over the forecast period. For instance in October 2020, Aurobindo Pharma Ltd., a pharmaceutical company, announced that they received approval from the U.S. Food and Drug Administration for its generic acetaminophen injection. It is indicated for the treatment of pain in pediatric patients and adults.

Moreover, in 2018, Aurobindo Pharma Ltd. announced that they received approval from U.S. Food and Drug Administration to manufacture and market Vecuronium Bromide Injection, 10mg and 20mg for the U.S. markets. This drug is utilized as a part of general anesthesia to give skeletal muscle relaxation during mechanical ventilation or surgery.

Key features of the study:

This report provides an in-depth analysis of the global small molecule injectable drugs market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global small molecule injectable drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Novartis AG, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd. AstraZeneca Plc, Baxter International Inc., Fresenius Kabi AG, Cipla Limited., Mylan N.V., GlaxoSmithKline Plc., Johnson & Johnson, Sanofi S.A., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG (Genentech, Inc.), Amgen, Inc., Gilead Sciences, Inc., and Hikma Pharmaceuticals plc
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global small molecule injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small molecule injectable drugs market

Detailed Segmentation:

Global Small Molecule Injectable Drugs Market, By Drug Class:
- Chemotherapy
- Small Molecule Antibiotics
- Skeletal Muscle Relaxants
- Analgesics
- Anticoagulants
- Anticonvulsants
- Antivirals
- Others
Global Small Molecule Injectable Drugs Market, By Indication:
- Oncology
- Pain Management
- Cardiovascular Diseases
- Infectious Diseases
- CNS Diseases
- Others
Global Small Molecule Injectable Drugs Market, By Mode of Delivery:
- IV Set
- Infusion Pump
- Intravenous Injection
- Intramuscular Injection
- Subcutaneous Injection
Global Small Molecule Injectable Drugs Market, By End User:
- Hospitals
- Ambulatory Clinics
- Outpatient Facility
- Infusion Therapy Center
- Home Care
- Others
Global Small Molecule Injectable Drugs Market, By Region:
- North America
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Country:
  - U.K.
  - Germany
  - Italy
  - Spain
  - France
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Country:
  - Australia
  - India
  - China
  - Japan
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
- Middle East
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Novartis AG *
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma Ltd.
- AstraZeneca Plc
- Baxter International Inc.
- Fresenius Kabi AG
- Cipla Limited.
- Mylan N.V.
- GlaxoSmithKline Plc.
- Johnson & Johnson
- Sanofi S.A.
- Reddy's Laboratories Ltd.
- Hoffmann-La Roche AG (Genentech, Inc.)
- Amgen, Inc.
- Gilead Sciences, Inc.
- Hikma Pharmaceuticals plc

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Indication
- Market Snippet, By Mode Of Delivery
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Scenario
PEST Analysis
Recent Product Launch/Approval
Epidemiology
Mergers and Acquisitions

4. Global Small Molecule Injectable Drugs Market - Impact of Coronavirus (Covid-19) Pandemic

Impact on Supply Chain
Impact on Research and Development
Government Initiatives

5. Global Small Molecule Injectable Drugs Market, By Drug Class, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Small Molecule Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Skeletal Muscle Relaxants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

6. Global Small Molecule Injectable Drugs Market, By Indication, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
CNS Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

7. Global Small Molecule Injectable Drugs Market, By Mode of Delivery, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
IV Set
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Infusion Pump
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Intravenous Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Intramuscular Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Subcutaneous Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Small Molecule Injectable Drugs Market, By End User, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Ambulatory Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Outpatient Facility
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Infusion Therapy Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Home Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

9. Global Small Molecule Injectable Drugs Market, By Region, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018 - 2030
- Regional Trends
North America
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- South Africa
- Central Africa
- North Africa

10. Competitive Landscape

Company Profiles
- Novartis AG
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer, Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Merck & Co., Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Aurobindo Pharma Ltd.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- AstraZeneca Plc
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Baxter International Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Fresenius Kabi AG
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Cipla Limited.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Mylan N.V.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GlaxoSmithKline Plc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Johnson & Johnson
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi S.A.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Reddy's Laboratories Ltd.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Hoffmann-La Roche AG (Genentech, Inc.)
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Amgen, Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Gilead Sciences, Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Hikma Pharmaceuticals plc
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
Analyst Views

11. Section

References
Research Methodology
About us and Sales Contact

低分子注射剤の市場規模・シェア・展望・機会 (2022年～2030年)：薬剤クラス・適応症・投薬モード・エンドユーザー・地域別

Small Molecule Injectable Drugs Market, by Drug Class, by Indication, by Mode of Delivery, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・規制・動向分析

第4章世界の低分子注射剤市場：COVID-19の影響

第5章世界の低分子注射剤市場：薬剤クラス別

第6章世界の低分子注射剤市場：適応症別

第7章世界の低分子注射剤市場：投薬モード別

第8章世界の低分子注射剤市場：エンドユーザー別

第9章世界の低分子注射剤市場：地域別

第10章競合情勢

第11章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Small Molecule Injectable Drugs Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Small Molecule Injectable Drugs Market, By Drug Class, 2017-2030 (US$ Million)

6. Global Small Molecule Injectable Drugs Market, By Indication, 2017 - 2030 (US$ Million)

7. Global Small Molecule Injectable Drugs Market, By Mode of Delivery, 2017 - 2030 (US$ Million)

8. Global Small Molecule Injectable Drugs Market, By End User, 2017 - 2030 (US$ Million)

9. Global Small Molecule Injectable Drugs Market, By Region, 2017 - 2030 (US$ Million)

10. Competitive Landscape

11. Section

低分子注射剤の市場規模・シェア・展望・機会 (2022年～2030年)：薬剤クラス・適応症・投薬モード・エンドユーザー・地域別

Small Molecule Injectable Drugs Market, by Drug Class, by Indication, by Mode of Delivery, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・規制・動向分析

第4章 世界の低分子注射剤市場：COVID-19の影響

第5章 世界の低分子注射剤市場：薬剤クラス別

第6章 世界の低分子注射剤市場：適応症別

第7章 世界の低分子注射剤市場：投薬モード別

第8章 世界の低分子注射剤市場：エンドユーザー別

第9章 世界の低分子注射剤市場：地域別

第10章 競合情勢

第11章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Small Molecule Injectable Drugs Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Small Molecule Injectable Drugs Market, By Drug Class, 2017-2030 (US$ Million)

6. Global Small Molecule Injectable Drugs Market, By Indication, 2017 - 2030 (US$ Million)

7. Global Small Molecule Injectable Drugs Market, By Mode of Delivery, 2017 - 2030 (US$ Million)

8. Global Small Molecule Injectable Drugs Market, By End User, 2017 - 2030 (US$ Million)

9. Global Small Molecule Injectable Drugs Market, By Region, 2017 - 2030 (US$ Million)

10. Competitive Landscape

11. Section

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・規制・動向分析

第4章世界の低分子注射剤市場：COVID-19の影響

第5章世界の低分子注射剤市場：薬剤クラス別

第6章世界の低分子注射剤市場：適応症別

第7章世界の低分子注射剤市場：投薬モード別

第8章世界の低分子注射剤市場：エンドユーザー別

第9章世界の低分子注射剤市場：地域別

第10章競合情勢

第11章セクション